Skip to Content

81 Results Found

  • Article
  • Open Access
30 Citations
6,529 Views
11 Pages

Quality of Life in Myasthenia Gravis and Correlation of MG-QOL15 with Other Functional Scales

  • Laura Diez Porras,
  • Christian Homedes,
  • Maria Antonia Alberti,
  • Valentina Velez Santamaria and
  • Carlos Casasnovas

14 April 2022

Health-related quality of life (HRQOL) in myasthenia gravis (MG) is frequently decreased. Further, there are many validated clinical scales and questionnaires to evaluate the clinical status in MG. We aimed to determine if there was an improvement in...

(This article belongs to the Section Clinical Neurology)
  • Article
  • Open Access
11 Citations
3,350 Views
12 Pages

Evaluation of the Quality of Life of Patients with Myasthenia Gravis in Greece

  • Afrodite Aggelina,
  • Eleftheria Karampli,
  • Georgios Mavrovounis,
  • Ioannis Boutsikos and ,
  • Ioannis Pantazopoulos,
  • Sotirios Kakavas,
  • Elpida Pavi and
  • Kostas Athanasakis
  • + 3 authors+ 0 author

12 July 2023

Myasthenia Gravis (MG) patients often report an affected quality of life (QoL). The aim of the current study was to evaluate the QoL of patients with MG in Greece using a specific tool. A cross-sectional online survey was performed. Adult patients we...

(This article belongs to the Section Personalized Therapy in Clinical Medicine)
  • Article
  • Open Access
5 Citations
4,704 Views
18 Pages

Real-World Case Series of Ravulizumab Use in Patients with Myasthenia Gravis in Romania

  • Crisanda Vîlciu,
  • Oana Antonia Mihalache,
  • Bogdan Marius Istrate,
  • Mihaela Aftinia Marian and ,
  • Mirela Ramona Drăghici,
  • Diana Mihaela Petrescu,
  • Adriana Octaviana Dulămea and
  • Daniela Cristina Anghel
  • + 3 authors+ 0 author

Background and Objectives: Ravulizumab, a long-acting C5 complement inhibitor, was approved in the US and Europe in 2022 as an add-on therapy for the standard treatment of AChR-positive generalized MG (gMG). We share our real-world experience with ad...

(This article belongs to the Special Issue Diagnosis, Therapy and Rehabilitation in Neuromuscular Diseases)
  • Article
  • Open Access
1 Citations
1,501 Views
21 Pages

15 February 2026

Background/Objectives: This study examined the prevalence of adverse childhood experiences (ACEs) among patients with myasthenia gravis (MG) and explored associations between ACE exposure and psychological outcomes. In addition, this study conducted...

(This article belongs to the Section Mental Health and Psychosocial Well-being)
  • Article
  • Open Access
26 Citations
8,926 Views
12 Pages

Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled Trial

  • Anna Ozaki,
  • Takaomi Kessoku,
  • Kosuke Tanaka,
  • Atsushi Yamamoto and ,
  • Kota Takahashi,
  • Yuma Takeda,
  • Yuki Kasai,
  • Michihiro Iwaki,
  • Takashi Kobayashi and
  • Atsushi Nakajima
  • + 19 authors+ 14 authors

24 April 2022

Opioid-induced constipation (OIC) may occur in patients receiving opioid treatment, decreasing their quality of life (QOL). We compared the effectiveness of magnesium oxide (MgO) with that of naldemedine (NAL) in preventing OIC. This proof-of-concept...

(This article belongs to the Special Issue Palliative and Supportive Care in Oncology: An Update)
  • Article
  • Open Access
11 Citations
4,208 Views
13 Pages

The Study of Nutrient Intake and Adolescent Girls’ Quality of Life in a Rural Area of Indonesia

  • Puspa Sari,
  • Dewi Marhaeni Diah Herawati,
  • Meita Dhamayanti and
  • Dany Hilmanto

19 August 2022

An inadequate nutrient intake correlates with malnutrition, a problem affecting many adolescents worldwide. Nutrient intake is associated with quality of life (QoL). Our study analyzed the relationship between nutrient intake and adolescents’ Q...

(This article belongs to the Special Issue Advances in Research on Nutrition and Childhood Obesity)
  • Article
  • Open Access
10 Citations
2,514 Views
10 Pages

Uncovering the Differences: How DLQI and WHO-5 Scores Vary in Moderate-to-Severe Psoriasis Patients Treated with Tildrakizumab 100 mg vs. 200 mg?

  • Emanuele Trovato,
  • Martina Dragotto,
  • Eugenio Capalbo,
  • Alessandra Cartocci and ,
  • Pietro Rubegni and
  • Laura Calabrese
  • + 1 author+ 0 author

4 September 2024

Background/Objectives: Psoriasis (PsO) is a chronic inflammatory skin disease that severely impacts patients’ quality of life (QoL). Its global prevalence is about 2%, with significant regional variations. PsO manifests in the form of erythemat...

(This article belongs to the Special Issue Targeted Treatment of Skin Inflammation)
  • Article
  • Open Access
5 Citations
2,887 Views
8 Pages

Similar Levels of Efficacy of Two Different Maintenance Doses of Adalimumab on Clinical Severity and Quality of Life of Patients with Hidradenitis Suppurativa

  • Luca Fania,
  • Giulia Giovanardi,
  • Tonia Samela,
  • Dante Caposiena and ,
  • Andrea Chiricozzi,
  • Flaminia Antonelli,
  • Pierluigi Saraceni,
  • Fulvia Elia,
  • Simone Garcovich and
  • Damiano Abeni
  • + 15 authors+ 10 authors

12 July 2022

Adalimumab is the only biologic agent approved for the treatment of moderate-to-severe hidradenitis suppurativa (HS) patients (i.e., with Hurley II or III), which is recommended in two different maintenance doses (i.e., 40 mg weekly or 80 mg every tw...

(This article belongs to the Special Issue Clinical Epidemiology of Skin Diseases)
  • Article
  • Open Access
15 Citations
8,306 Views
13 Pages

23 September 2020

Curcumin has previously been shown to enhance mood in non-depressed older adults. However, observed benefits were limited to short-term supplementation (4 weeks). In a 16 week randomized, double-blind, placebo-controlled, 2 × 2 factorial design...

(This article belongs to the Special Issue Dietary Curcumin and Health Effects)
  • Article
  • Open Access
1,204 Views
12 Pages

Perceived Fatigue and Associated Psychological Factors in Patients with Myasthenia Gravis

  • Weronika Jung-Plath,
  • Marcelina Skrzypek-Czerko,
  • Agata Zdun-Ryżewska,
  • Małgorzata Bilińska and
  • Wioletta Mędrzycka-Dąbrowska

29 January 2026

Introduction: Myasthenia gravis (MG) is a chronic autoimmune disorder in which fatigue represents one of the most burdensome symptoms. This multidimensional manifestation extends beyond neuromuscular fatigability and has a substantial impact on daily...

(This article belongs to the Special Issue Challenges in Health and Nursing Care Within the Community-Based Integrated Care System)
  • Article
  • Open Access
8 Citations
18,542 Views
9 Pages

The Effects of Omega-3 Supplementation on the Omega-3 Index and Quality of Life and Pain Scores in Dogs

  • Carolina Carlisle,
  • Brandon T. Metzger,
  • Nathan L. Tintle,
  • Kristine Polley and ,
  • Kristina H. Jackson,
  • Sara Le Brun-Blashka,
  • Jody Griffiths and
  • William S. Harris
  • + 3 authors+ 0 author

29 October 2024

This study in dogs had two objectives: first, to determine whether a daily supplement of marine omega-3 (EPA and DHA) would (1) increase red blood cell EPA + DHA levels (i.e., the Omega-3 Index derived from dried blood spot analysis) and (2) impact h...

(This article belongs to the Section Companion Animals)
  • Article
  • Open Access
51 Citations
7,247 Views
13 Pages

Astragalus polysaccharide (PG2) Ameliorates Cancer Symptom Clusters, as well as Improves Quality of Life in Patients with Metastatic Disease, through Modulation of the Inflammatory Cascade

  • Wen-Chien Huang,
  • Kuang-Tai Kuo,
  • Oluwaseun Adebayo Bamodu,
  • Yen-Kuang Lin and ,
  • Chun-Hua Wang,
  • Kang-Yun Lee,
  • Liang-Shun Wang,
  • Chi-Tai Yeh and
  • Jo-Ting Tsai
  • + 4 authors+ 0 author

25 July 2019

Background: Improving patients’ quality of life (QoL) is a principal objective of all treatment in any clinical setting, including oncology practices. Cancer-associated inflammation is implicated in disease progression and worsening of patients...

  • Article
  • Open Access
1 Citations
2,741 Views
15 Pages

Effect of Safinamide on Non-Motor Symptoms and Quality of Life in Parkinson’s Disease Patients According to Sex, Age, Disease Duration and Levodopa Equivalent Daily Dose

  • Ángela Solleiro Vidal,
  • Rosa Yáñez Baña,
  • Carmen Labandeira Guerra,
  • Maria Icíar Cimas Hernando and ,
  • Iria Cabo López,
  • Jose Manuel Paz González,
  • Maria Gema Alonso Losada and
  • Diego Santos García
  • + 3 authors+ 0 author

Background and objective: Safinamide can improve the non-motor symptoms (NMSs) and quality of life (QoL) in patients with Parkinson’s disease (PD). In this post hoc analysis of the SAFINONMOTOR study, we analyzed the effect of safinamide on NMS...

(This article belongs to the Section Neuropharmacology and Neuropathology)
  • Article
  • Open Access
3 Citations
11,743 Views
16 Pages

Impact of Toceranib Phosphate and Carprofen on Survival and Quality of Life in Dogs with Inflammatory Mammary Carcinomas

  • Miguel Garcia-de la Virgen,
  • Isabel Del Portillo Miguel,
  • Elisa Maiques,
  • Ignacio Pérez Roger and ,
  • Enric Poch and
  • Juan Borrego
  • + 1 author+ 0 author

13 September 2024

Canine inflammatory mammary carcinoma (IMC) is an aggressive and rare type of mammary gland cancer in dogs where vascular endothelial growth factor and cyclooxigenase-2 overexpression usually occur, which contribute to its invasive and angiogenic nat...

(This article belongs to the Special Issue Focus on Tumours in Pet Animals)
  • Article
  • Open Access
1 Citations
557 Views
15 Pages

24 August 2026

Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder that significantly impairs patients’ quality of life. Antispasmodics such as mebeverine and otilonium bromide (OB) are commonly used as first-line therapies; however,...

(This article belongs to the Special Issue Gastrointestinal Health: Clinical Research and Therapeutic Innovations—2nd Edition)
  • Systematic Review
  • Open Access
1 Citations
2,523 Views
14 Pages

Physical Exercise in Myasthenia Gravis: A Systematic Review

  • Claudia Vinciguerra,
  • Ignazio Leale,
  • Nicasio Rini,
  • Fabio Tiziano Orlando and ,
  • Liliana Bevilacqua,
  • Paolo Barone,
  • Filippo Brighina,
  • Vincenzo Di Stefano and
  • Giuseppe Battaglia
  • + 4 authors+ 0 author

Background: Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by fluctuating skeletal muscle weakness and fatigue, leading to reduced functional independence and impaired quality of life (QoL). Although exercise has historically b...

  • Article
  • Open Access
3 Citations
3,077 Views
10 Pages

The Perceived Effectiveness of Cannabidiol on Adult Women with Inflammatory Bowel Disease

  • Ayelet Portman,
  • Emily Bukovich,
  • Janice Bissex,
  • Molly Flanagan and
  • Rachele Pojednic

14 December 2024

Background and Objectives: In this study we analyzed the perceived effectiveness of cannabidiol (CBD) in adult women with inflammatory bowel disease (IBD). Materials and Methods: We conducted an online cross-sectional survey which assessed disease se...

(This article belongs to the Section Gastroenterology & Hepatology)
  • Article
  • Open Access
7 Citations
6,094 Views
12 Pages

Background and Objectives: Previous studies have shown that the levodopa treatment of Parkinson’s disease (PD) elevates circulating homocysteine levels, which are associated with an increased risk of cardiovascular and neurological disorders, or thro...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
4 Citations
19,543 Views
9 Pages

Efficacy of High-Dose Diosmin Therapy in Chronic Venous Disease Treated with Endovenous Ablation: A Quality-of-Life Analysis

  • Antonia Rinaldi,
  • Rita Zeno,
  • Antonio Peluso,
  • Luca del Guercio and ,
  • Maurizio Sodo,
  • Davide Turchino,
  • Ruggero Iandoli,
  • Davide Costa,
  • Raffaele Serra and
  • Umberto Marcello Bracale
  • + 5 authors+ 0 author

1 February 2024

Background. Vasoactive drugs are considered an important therapeutic tool in managing phlebolymphologic disease. The current study was performed to evaluate the results of a high-dose diosmin-based combination (Venoplant 2g) in symptomatic patients w...

(This article belongs to the Section Peripheral Vascular Diseases)
  • Article
  • Open Access
9 Citations
15,481 Views
20 Pages

The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study

  • Ursula Wade,
  • Domingo A. Pascual-Figal,
  • Fazale Rabbani,
  • Marie Ernst and ,
  • Adelin Albert,
  • Isabelle Janssens,
  • Yvan Dierckxsens,
  • Somia Iqtadar,
  • Nisar A. Khokhar and
  • Amjad Khan
  • + 6 authors+ 1 author

18 April 2024

Irritable bowel syndrome (IBS) is a prevalent chronic functional gastrointestinal disorder, characterised by recurrent abdominal discomfort and altered bowel movements. IBS cause a significantly negative impact on quality of life (QoL). Growing pharm...

(This article belongs to the Special Issue Natural Products and Human Health)
  • Article
  • Open Access
42 Citations
15,491 Views
12 Pages

Efficacy of a Low-Dose Diosmin Therapy on Improving Symptoms and Quality of Life in Patients with Chronic Venous Disease: Randomized, Double-Blind, Placebo-Controlled Trial

  • Raffaele Serra,
  • Nicola Ielapi,
  • Andrea Bitonti,
  • Stefano Candido and ,
  • Salvatore Fregola,
  • Alessandro Gallo,
  • Antonio Loria,
  • Lucia Muraca,
  • Luca Raimondo and
  • Luca Gallelli
  • + 7 authors+ 2 authors

19 March 2021

Chronic Venous Disease (CVD) is a common medical condition affecting up to 80% of the general population. Clinical manifestations can range from mild to more severe signs and symptoms that contribute to the impairment of the quality of life (QoL) of...

(This article belongs to the Special Issue Effect of Diet on Vascular Function and Hormones)
  • Article
  • Open Access
2 Citations
1,447 Views
16 Pages

Background/Objectives: Iron deficiency without anaemia (IDNA) is common in non-dialysis-dependent chronic kidney disease (CKD) and contributes to fatigue, reduced exercise tolerance, and impaired quality of life (QoL). While intravenous (IV) iron rep...

(This article belongs to the Special Issue Emerging Trends in Kidney Disease)
  • Study Protocol
  • Open Access
23 Citations
5,094 Views
11 Pages

PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System

  • Anouk Corbeau,
  • Remi A. Nout,
  • Jan Willem M. Mens,
  • Nanda Horeweg and ,
  • Jérémy Godart,
  • Ellen M. Kerkhof,
  • Sander C. Kuipers,
  • Mariette I. E. van Poelgeest,
  • Judith R. Kroep and
  • Stephanie M. de Boer
  • + 13 authors+ 8 authors

15 October 2021

External beam radiation therapy (EBRT) with concurrent chemotherapy followed by brachytherapy is a very effective treatment for locally advanced cervical cancer (LACC). However, treatment-related toxicity is common and reduces the patient’s quality o...

(This article belongs to the Special Issue Advances in Gynecological Oncology: From Pathogenesis to Therapy)
  • Article
  • Open Access
7 Citations
6,213 Views
12 Pages

Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study

  • Antonio Alcaraz,
  • Mauro Gacci,
  • Vincenzo Ficarra,
  • José Medina-Polo and ,
  • Andrea Salonia,
  • Jesús M. Fernández-Gómez,
  • Alexandru Ciudin,
  • David Castro-Díaz,
  • Alfredo Rodríguez-Antolín and
  • on behalf of the QUALIPROST Study Group
  • + 15 authors+ 10 authors

12 February 2022

We investigated changes in symptoms and quality of life (QoL) in men with moderate-to-severe lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) receiving the hexanic extract of Serenoa repens (HESr) and compared resu...

(This article belongs to the Section Nephrology & Urology)
  • Article
  • Open Access
362 Views
16 Pages

20 October 2026

Background/Objectives: This study aimed to compare oral citicoline 500 mg/homotaurine 50 mg/nicotinamide 54 mg/pyrroloquinoline quinone 5 mg (CIT/HOMO/B3/PQQ) with citicoline 500 mg alone (CIT500) for contrast sensitivity (CS), vision-related quality...

(This article belongs to the Section Neurodegenerative Diseases)
  • Article
  • Open Access
1 Citations
12,453 Views
11 Pages

The Effect of Electrolyzed Hydrogen-Rich Alkaline Reduced Water on Patients with Chronic Constipation—A Clinical Trial

  • Subham Sharma,
  • Yundeok Kim,
  • Johny Bajgai,
  • Md. Habibur Rahman and ,
  • Yun Ju Jeong,
  • Seong Hoon Goh,
  • Hong Jun Park,
  • Cheol-Su Kim,
  • Hyun Il Kim and
  • Kyu-Jae Lee
  • + 5 authors+ 0 author

18 July 2023

Chronic constipation is a common symptom-based disorder that affects patient quality of life. Electrolyzed hydrogen-rich alkaline reduced water (EHARW) helps treat gastrointestinal disorders owing to its various bioactive properties. This single-arm,...

(This article belongs to the Section Biological Processes and Systems)
  • Article
  • Open Access
948 Views
17 Pages

Impact of Time of Administration, Fasting, and a Low-Carbohydrate Diet on Alpelisib-Associated Hyperglycemia and Efficacy: A Pilot Randomized Controlled Phase IIb Trial

  • Eduard Vrdoljak,
  • Marija Pancirov,
  • Josipa Flam,
  • Dora Čerina Pavlinović and ,
  • Matea Jakas Vučić,
  • Marica Barać,
  • Natalija Dedić Plavetić,
  • Paula Podolski,
  • Mladen Krnić and
  • Žarko Bajić
  • + 5 authors+ 0 author

3 April 2026

Background: Alpelisib plus fulvestrant improves outcomes in PIK3CA-mutated, hormone receptor-positive, HER2-negative metastatic breast cancer. However, on-target hyperglycemia often leads to dose modification or discontinuation. We aimed primarily to...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
6 Citations
7,644 Views
15 Pages

Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients

  • Maria del Mar Ras-Jiménez,
  • Raúl Ramos-Polo,
  • Josep Francesch Manzano,
  • Miriam Corbella Santano and ,
  • Herminio Morillas Climent,
  • Núria Jose-Bazán,
  • Santiago Jiménez-Marrero,
  • Paloma Garcimartin Cerezo,
  • Sergi Yun Viladomat and
  • Josep Comin-Colet
  • + 15 authors+ 10 authors

21 August 2023

The soluble transferrin receptor (sTfR) is a marker of tissue iron status, which could indicate an increased iron demand at the tissue level. The impact of sTfR levels on functional capacity and quality of life (QoL) in non-anemic heart failure (HF)...

(This article belongs to the Section Mechanisms of Diseases)
  • Systematic Review
  • Open Access
18 Citations
7,460 Views
23 Pages

Remote Rehabilitation and Virtual Reality Interventions Using Motion Sensors for Chronic Low Back Pain: A Systematic Review of Biomechanical, Pain, Quality of Life, and Adherence Outcomes

  • Marina Garofano,
  • Rosaria Del Sorbo,
  • Mariaconsiglia Calabrese,
  • Massimo Giordano and ,
  • Maria Pia Di Palo,
  • Marianna Bartolomeo,
  • Chiara Maria Ragusa,
  • Gaetano Ungaro,
  • Gianluca Fimiani and
  • Alessia Bramanti
  • + 11 authors+ 6 authors

Background: Chronic low back pain (CLBP) is a leading cause of disability, impacting quality of life (QoL), function, and work productivity. Traditional rehabilitation faces challenges in accessibility and adherence. Remote rehabilitation and virtual...

(This article belongs to the Special Issue Assistive Technologies in Care and Rehabilitation: Research, Developments, and International Initiatives)
  • Article
  • Open Access
1 Citations
1,283 Views
16 Pages

29 May 2026

Background: Lower urinary tract symptoms (LUTS) are prevalent among aging men and negatively affect quality of life. Salvia miltiorrhiza extract (SAGX), which exhibits anti-inflammatory and antioxidant properties, has been developed as a functional i...

(This article belongs to the Topic Functional Foods and Nutraceuticals in Health and Disease)
  • Article
  • Open Access
6 Citations
2,796 Views
11 Pages

Comparative Approaches in Treating Double-J Stent Syndrome: Monotherapy or Combination Therapy?

  • Cătălin Pricop,
  • Carina Alexandra Bandac,
  • Marius Ivanuță,
  • Daniel Rădăvoi and ,
  • Viorel Jinga and
  • Dragoş Puia
  • + 1 author+ 0 author

22 July 2024

Introduction: The application of double-J ureteral stents in urology is widespread, but their use is often accompanied by complications and bothersome symptoms, affecting patients’ quality of life (QoL). While various medications have been test...

(This article belongs to the Section Nephrology & Urology)
  • Article
  • Open Access
11 Citations
11,400 Views
14 Pages

Pharmacokinetics of Repeated Oral Dosing with Coenzyme Q10 in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease

  • Liselotte B. Christiansen,
  • Malene K. Morsing,
  • Maria Josefine Reimann,
  • Torben Martinussen and ,
  • Zita Birlie,
  • Anne Marie V. Schou-Pedersen,
  • Jens Lykkesfeldt and
  • Lisbeth H. Olsen
  • + 3 authors+ 0 author

4 September 2020

Coenzyme Q10 (Q10) is a mitochondrial cofactor and an antioxidant with the potential to combat oxidative stress in heart failure. This study aims to determine the pharmacokinetics of repeated oral dosing of Q10 in Cavalier King Charles Spaniels (CKCS...

(This article belongs to the Special Issue Antioxidants in Veterinary Medicine)
  • Article
  • Open Access
924 Views
20 Pages

Potential Adjunctive Effects of Quercetin–Curcumin Co-Supplementation in Adults with Mild-to-Moderate Long COVID: Results from a Pragmatic Exploratory Real-World Clinical Study

  • Amjad Khan,
  • Fazle Rabbani,
  • Sami Ullah Mumtaz,
  • Roha Javed and ,
  • Ikram Ujjan,
  • Ayesha Kanwal and
  • Gabriele Conti
  • + 2 authors+ 0 author

31 July 2026

Background/Objectives: Long COVID is characterised by persistent symptoms such as fatigue, pain, cognitive impairment, sleep disturbances, and reduced quality of life (QoL) following SARS-CoV-2 infection. Proposed mechanisms include persistent immune...

(This article belongs to the Special Issue Metabolism, Inflammation and Neurodegeneration: Natural Compounds as Therapeutic Agents)
  • Article
  • Open Access
420 Views
17 Pages

Treatment Patterns, Disease Management, and Quality of Life in Outpatients with CKD and Decreased eGFR: A Multicenter Prospective Observational Study in Greece

  • Evangelia Ntounousi,
  • Kostantinos Stylianou,
  • Smaragdi Marinaki,
  • Vassilios Liakopoulos and ,
  • Sofia Lionaki,
  • Ioannis Stefanidis,
  • Stylianos Panagoutsos,
  • Dimitrios Goumenos,
  • Dimitrios Xidakis and
  • Dimitriοs Petras
  • + 11 authors+ 6 authors

17 September 2026

Background/Objectives: Chronic kidney disease (CKD) is a major cause of morbidity and mortality. Evidence on routine management and patient-reported outcomes in Greece is limited. The SPIRIT study assessed real-world treatment patterns, disease manag...

(This article belongs to the Special Issue Managing Chronic Kidney Disease: Current Practices and Future Perspectives)
  • Study Protocol
  • Open Access
18 Citations
13,260 Views
11 Pages

Effects of Microencapsulated Sodium Butyrate, Probiotics and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome: A Study Protocol of a Randomized Double-Blind Placebo-Controlled Trial

  • Anita Gąsiorowska,
  • Marek Romanowski,
  • Ewa Walecka-Kapica,
  • Aleksandra Kaczka and ,
  • Cezary Chojnacki,
  • Milena Padysz,
  • Marta Siedlecka,
  • Joanna B. Bierła,
  • Robert E. Steinert and
  • Bożena Cukrowska
  • + 5 authors+ 0 author

7 November 2022

Irritable bowel syndrome (IBS) is a functional gastrointestinal disease in the pathogenesis of which gut dysbiosis may play an important role. Thus, probiotics, prebiotics, or microbiota metabolites, such as butyric acid, are considered to be effecti...

(This article belongs to the Special Issue The Role of Gut Microbiome in Health and Disease: A Clinical Update)
  • Article
  • Open Access
5 Citations
3,111 Views
12 Pages

One Incremental Stride for Doxycycline, One Substantial Advancement for Thyroid Eye Disease

  • Ines Matoc,
  • Kim Kasa,
  • Armin Kasumović,
  • Ante Prpić and ,
  • Ante Vukojević,
  • Ognjen Zrinšćak,
  • Jelena Škunca Herman,
  • Blanka Doko Mandić,
  • Ivan Sabol and
  • Zoran Vatavuk
  • + 6 authors+ 1 author

The aim of this study is to assess the effectiveness of a 12-week doxycycline treatment for thyroid eye disease (TED), an autoimmune condition associated with thyroid dysfunction. In this randomized controlled clinical trial, 82 patients were randoml...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
3 Citations
3,006 Views
23 Pages

Phospholipid-Based Delivery System Optimizes the Solubility and Systemic Exposure of Palmitoylethanolamide and Supports Clinical Benefits in Chronic Neuropathic Low Back Pain

  • Amjad Khan,
  • Fazle Rabbani,
  • Ayesha Kanwal,
  • Areaba Shafiq and ,
  • Ikram Ujjan,
  • Anna Vellaccio,
  • Massimo Ronchi,
  • Giovanna Petrangolini,
  • Eric De Combarieu and
  • Gabriele Conti
  • + 6 authors+ 1 author

Background: Chronic neuropathic low back pain (LBP) is a prevalent health condition and difficult to treat. Conventional therapies often provide limited relief and raise safety concerns. Supplemental palmitoylethanolamide (PEA), an endogenous fatty a...

(This article belongs to the Section Cell Biology and Pathology)
  • Abstract
  • Open Access
1 Citations

Effects of ginger supplementation in individuals with mild-to-moderate joint pain II: joint flexibility, markers of health, quality of life, analgesic use, and side effects

  • Landry Estes,
  • Jacob Broeckel,
  • Megan Leonard,
  • Broderick Dickerson and ,
  • Drew E. Gonzalez,
  • Martin Purpura,
  • Ralf Jäger,
  • Ryan Sowinski,
  • Christopher J. Rasmussen and
  • Richard B. Kreider
  • + 5 authors+ 0 author

Background: Ginger contains gingerols, shogaols, paradols, gingerdiones, and terpenes which have shown to display anti-inflammatory properties and inhibit pain receptors. For this reason, ginger has been marketed as a natural ingredient for joint hea...

  • Article
  • Open Access
3 Citations
5,019 Views
16 Pages

Real-World Outcomes and Healthcare Utilization of Lanadelumab in Spain: Insights from First Cohort of Difficult-to-Treat Hereditary Angioedema Cases

  • Inmaculada Sánchez-Machín,
  • Ruperto González-Pérez,
  • Elena Mederos-Luis,
  • Sara García-Gil and
  • Paloma Poza-Guedes

11 February 2025

Background/Objectives: Hereditary angioedema (HAE) is a rare genetic condition marked by recurring episodes of intense swelling that affect the skin, gastrointestinal system, and airways. Lanadelumab, a monoclonal antibody that inhibits plasma kallik...

(This article belongs to the Section Diagnosis and Therapeutics)
  • Article
  • Open Access
132 Citations
44,997 Views
14 Pages

Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial

  • Triantafyllos Didangelos,
  • Eleni Karlafti,
  • Evangelia Kotzakioulafi,
  • Eleni Margariti and ,
  • Parthena Giannoulaki,
  • Georgios Batanis,
  • Solomon Tesfaye and
  • Kοnstantinos Kantartzis
  • + 3 authors+ 0 author

27 January 2021

Aim: To investigate the effect of normalizing vitamin B12 (B12) levels with oral B12 (methylcobalamin) 1000 μg/day for one year in patients with diabetic neuropathy (DN). Patients and methods: In this prospective, double-blind, placebo-controlled...

(This article belongs to the Special Issue Dietary Intake and Diabetes)
  • Article
  • Open Access
2,147 Views
12 Pages

Integrated Evaluation of CPAP Therapy in Type 2 Diabetic Patients with Sleep Apnea: Quality of Life and Effects on Metabolic Function and Inflammation in Outpatient Care

  • Petar Kalaydzhiev,
  • Tsvetelina Velikova,
  • Yanitsa Davidkova,
  • Radostina Ilieva and ,
  • Elena Kinova and
  • Emilia Naseva
  • + 1 author+ 0 author

Background. Type 2 diabetes mellitus (T2D) and moderate-to-severe obstructive sleep apnea (OSA) commonly coexist and exacerbate poor glycemic control, systemic inflammation, and diminished quality of life (QoL). Although continuous positive airway pr...

  • Article
  • Open Access
46 Citations
4,926 Views
11 Pages

Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

  • Celeste Lebbé,
  • Caroline Dutriaux,
  • Thierry Lesimple,
  • Willem Kruit and ,
  • Joseph Kerger,
  • Luc Thomas,
  • Bernard Guillot,
  • Filippo de Braud,
  • Claus Garbe and
  • Brigitte Dréno
  • + 15 authors+ 10 authors

29 June 2020

This study investigated the efficacy and safety of pimasertib (MEK1/MEK2 inhibitor) versus dacarbazine (DTIC) in patients with untreated NRAS-mutated melanoma. Phase II, multicenter, open-label trial. Patients with unresectable, stage IIIc/IVM1 NRAS-...

(This article belongs to the Special Issue Targeted Therapies for Melanoma)
  • Article
  • Open Access
3 Citations
3,414 Views
16 Pages

A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients

  • Gabriella Paparella,
  • Cristina Stragà,
  • Nicola Pesenti,
  • Valentina Dal Molin and ,
  • Gian Antonio Martorel,
  • Vasco Merotto,
  • Cristina Genova,
  • Arianna Piazza,
  • Giuseppe Piccoli and
  • Andrea Martinuzzi
  • + 8 authors+ 3 authors

9 August 2024

Background: A drug repositioning effort supported the possible use of the anti-HIV drug etravirine as a disease-modifying drug for Friedreich ataxia (FRDA). Etravirine increases frataxin protein and corrects the biochemical defects in cells derived f...

(This article belongs to the Section Pediatric Neurology & Neurodevelopmental Disorders)
  • Article
  • Open Access
642 Views
11 Pages

IV Vitamin C with Chemotherapy for Cisplatin-Ineligible Bladder Cancer Patients: A Forgotten Group

  • John A. Taylor,
  • Rahul A. Parikh,
  • Qi Chen,
  • Benjamin L. Woolbright and ,
  • Ping Chen,
  • Junqiang Dai,
  • Mihaela Sardiu,
  • Joya He and
  • Jeanne Drisko
  • + 4 authors+ 0 author

13 October 2026

Purpose: Neoadjuvant cisplatin-based chemotherapy (NAC) is considered the standard of care (SOC) for patients with muscle-invasive bladder cancer (MIBC). However, approximately 50% of patients are cisplatin-ineligible (CI) and often proceed directly...

(This article belongs to the Special Issue Vitamin C in Cancer Therapy)
  • Article
  • Open Access
940 Views
13 Pages

Efficacy, Safety, and Hematologic Recovery Following Intravenous Ferric Carboxymaltose in Patients with Iron Malabsorption-Related Iron Deficiency Anemia: A Prospective Clinical Study

  • Silvia Scalamonti,
  • Giulia Pivetta,
  • Francesco Paolo Schiavone,
  • Micaela Magnante and ,
  • Manuela Pompili,
  • Marica Vavallo,
  • Bruno Annibale and
  • Edith Lahner
  • + 3 authors+ 0 author

4 June 2026

Background/Objectives: Autoimmune gastritis (AIG), celiac disease (CD), and gastric surgery (GS) often cause iron deficiency anemia (IDA) due to iron malabsorption. In this clinical context, IDA treatment is often challenging. The first-line IDA trea...

(This article belongs to the Section Micronutrients and Human Health)
  • Article
  • Open Access
14 Citations
6,143 Views
12 Pages

Effect of Bifidobacterium bifidum G9-1 on the Intestinal Environment and Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-like Symptoms in Patients with Quiescent Crohn’s Disease: A Prospective Pilot Study

  • Toshihiko Tomita,
  • Hirokazu Fukui,
  • Takuya Okugawa,
  • Takashi Nakanishi and ,
  • Masatoshi Mieno,
  • Keisuke Nakai,
  • Hirotsugu Eda,
  • Yoshitaka Kitayama,
  • Tadayuki Oshima and
  • Hiroto Miwa
  • + 6 authors+ 1 author

9 May 2023

Diarrhea-predominant irritable bowel syndrome (IBS-D)-like symptoms are distressing for patients with quiescent Crohn’s disease (qCD) and worsen their quality of life. In the present study, we assessed the effect of the probiotic Bifidobacteriu...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
  • Article
  • Open Access
5 Citations
3,737 Views
10 Pages

8 September 2022

Manifestations related to ongoing inflammation in systemic lupus erythematosus (SLE) are often adequately managed, but patient-reported outcome measures (PROMs) support that fatigue and low quality of life (QoL) in the absence of raised disease activ...

(This article belongs to the Special Issue Clinical Features and Long-Term Outcomes of Systemic Lupus Erythematosus)
  • Article
  • Open Access
8 Citations
5,275 Views
11 Pages

Phase 1 Study to Evaluate the Safety of Reducing the Prophylactic Dose of Dexamethasone around Docetaxel Infusion in Patients with Prostate and Breast Cancer

  • Rieneke T. Lugtenberg,
  • Stefanie de Groot,
  • Danny Houtsma,
  • Vincent O. Dezentjé and ,
  • Annelie J. E. Vulink,
  • Maarten J. Fischer,
  • Johanneke E. A. Portielje,
  • Jacobus J. M. van der Hoeven,
  • Hans Gelderblom and
  • Judith R. Kroep
  • + 6 authors+ 1 author

9 March 2023

Background: There is little evidence that supports the registered high dose of dexamethasone used around docetaxel. However, this high dose is associated with considerable side effects. This study evaluates the feasibility of reducing the prophylacti...

(This article belongs to the Section Clinical Research in Cancer)
  • Article
  • Open Access
17 Citations
3,558 Views
10 Pages

Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry

  • Michail Vikelis,
  • Emmanouil V. Dermitzakis,
  • Georgia Xiromerisiou,
  • Dimitrios Rallis and ,
  • Panagiotis Soldatos,
  • Pantelis Litsardopoulos,
  • Dimitrios Rikos and
  • Andreas A. Argyriou
  • + 3 authors+ 0 author

6 July 2023

Objective: this post hoc analysis aimed to evaluate the efficacy of fremanezumab in difficult-to-treat chronic migraine (CM) patients with and without psychiatric comorbidities (PCs), mainly anxiety and/or depression. Methods: We assessed data from C...

(This article belongs to the Special Issue Headache Disorders: New Advances in Management and Treatment Strategies)
  • Article
  • Open Access
7 Citations
3,175 Views
10 Pages

A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy

  • Karan Dixit,
  • Lauren Singer,
  • Sean Aaron Grimm,
  • Rimas V. Lukas and ,
  • Margaret A. Schwartz,
  • Alfred Rademaker,
  • Hui Zhang,
  • Masha Kocherginsky,
  • Sofia Chernet and
  • Priya Kumthekar
  • + 8 authors+ 3 authors

4 June 2024

Patients with solid tumor brain metastases that progress after whole-brain radiation have limited options. This prospective trial investigated the efficacy, safety, and tolerability of bevacizumab as salvage therapy in this population. Eligible patie...

(This article belongs to the Special Issue Brain Metastases: Diagnosis and Treatment)

of 2